Durvalumab,Tremelimumab
AstraZeneca,Pfizer
[]
interesting breakdown by histology and co-mutations (stk11, kras). smaller subsets but nice signals. no new safety signals here. #esmo22 
Director of Thoracic Oncology & Developmental Therapeutics @LombardiCancer, Associate Professor @Georgetown University #LCSM #HereWeGo #ITYSL He/Him